M J Pérez-Sáez1,2,3, S Herrera2,4,5, D Prieto-Alhambra2,5,6, L Vilaplana2,4,5, X Nogués2,4,5, M Vera1,2, D Redondo-Pachón1,2,3, M Mir1,2, R Güerri2,4,5, M Crespo1,2,3, A Díez-Pérez7,8,9, J Pascual10,11,12. 1. Department of Nephrology, Hospital del Mar, Autonomous University of Barcelona, Passeig Maritim 25-29, 08003, Barcelona, Spain. 2. Institut Mar d'Investigacions Mediques, Barcelona, Spain. 3. REDINREN, Instituto Carlos III, Madrid, Spain. 4. Department of Internal Medicine, Hospital del Mar, Autonomous University of Barcelona, Passeig Maritim 25-29, 08003, Barcelona, Spain. 5. RETICEF, Instituto Carlos III, Madrid, Spain. 6. Oxford NIHR Musculoskeletal Biomedical Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Windmill Road, Oxford, OX3 7HE, UK. 7. Institut Mar d'Investigacions Mediques, Barcelona, Spain. adiez@parcdesalutmar.cat. 8. Department of Internal Medicine, Hospital del Mar, Autonomous University of Barcelona, Passeig Maritim 25-29, 08003, Barcelona, Spain. adiez@parcdesalutmar.cat. 9. RETICEF, Instituto Carlos III, Madrid, Spain. adiez@parcdesalutmar.cat. 10. Department of Nephrology, Hospital del Mar, Autonomous University of Barcelona, Passeig Maritim 25-29, 08003, Barcelona, Spain. julpascual@gmail.com. 11. Institut Mar d'Investigacions Mediques, Barcelona, Spain. julpascual@gmail.com. 12. REDINREN, Instituto Carlos III, Madrid, Spain. julpascual@gmail.com.
Abstract
Bone health is assessed by bone mineral density (BMD). Other techniques such as trabecular bone score and microindentation could improve the risk of fracture's estimation. Our chronic kidney disease (CKD) patients presented worse bone health (density, microarchitecture, mechanical properties) than controls. More than BMD should be done to evaluate patients at risk of fracture. INTRODUCTION: BMD measured by dual-energy X-ray absorptiometry (DXA) is used to assess bone health in end-stage renal disease (ESRD) patients. Recently, trabecular bone score (TBS) and microindentation that can measure microarchitectural and mechanical properties of bone have demonstrated better correlation with fractures than DXA in different populations. We aimed to characterize bone health (BMD, TBS, and strength) and calcium/phosphate metabolism in a cohort of 53 ESRD patients undergoing kidney transplantation (KT) and 94 controls with normal renal function. METHODS: Laboratory workout, lumbar spine/hip BMD measurements (using DXA), lumbar spine TBS, and bone strength were carried out. The latter was assessed with an impact microindentation device, standardized as percentage of a reference value, and expressed as bone material strength index (BMSi) units. Multivariable linear regression was used to study differences between cases and controls adjusted by age, gender, and body mass index. RESULTS: Among cases, serum calcium was 9.6 ± 0.7 mg/dl, phosphorus 4.4 ± 1.2 mg/dl, and intact parathyroid hormone 214 pg/ml [102-390]. Fourteen patients (26.4%) had prevalent asymptomatic fractures in spinal X-ray. BMD was significantly lower among ESRD patients compared to controls: lumbar 0.966 ± 0.15 vs 0.982 ± 0.15 (adjusted p = 0.037), total hip 0.852 ± 0.15 vs 0.902 ± 0.13 (adjusted p < 0.001), and femoral neck 0.733 ± 0.15 vs 0.775 ± 0.12 (adjusted p < 0.001), as were TBS (1.20 [1.11-1.30] vs 1.31 [1.19-1.43] (adjusted p < 0.001)) and BMSi (79 [71.8-84.2] vs 82. [77.5-88.9] (adjusted p = 0.005)). CONCLUSIONS: ESRD patients undergoing transplant surgery have damaged bone health parameters (density, microarchitecture, and mechanical properties) despite acceptably controlled hyperparathyroidism. Detecting these abnormalities may assist in identifying patients at high risk of post-transplantation fractures.
Bone health is assessed by bone mineral density (BMD). Other techniques such as trabecular bone score and microindentation could improve the risk of fracture's estimation. Our chronic kidney disease (CKD) patients presented worse bone health (density, microarchitecture, mechanical properties) than controls. More than BMD should be done to evaluate patients at risk of fracture. INTRODUCTION: BMD measured by dual-energy X-ray absorptiometry (DXA) is used to assess bone health in end-stage renal disease (ESRD) patients. Recently, trabecular bone score (TBS) and microindentation that can measure microarchitectural and mechanical properties of bone have demonstrated better correlation with fractures than DXA in different populations. We aimed to characterize bone health (BMD, TBS, and strength) and calcium/phosphate metabolism in a cohort of 53 ESRDpatients undergoing kidney transplantation (KT) and 94 controls with normal renal function. METHODS: Laboratory workout, lumbar spine/hip BMD measurements (using DXA), lumbar spine TBS, and bone strength were carried out. The latter was assessed with an impact microindentation device, standardized as percentage of a reference value, and expressed as bone material strength index (BMSi) units. Multivariable linear regression was used to study differences between cases and controls adjusted by age, gender, and body mass index. RESULTS: Among cases, serum calcium was 9.6 ± 0.7 mg/dl, phosphorus 4.4 ± 1.2 mg/dl, and intact parathyroid hormone 214 pg/ml [102-390]. Fourteen patients (26.4%) had prevalent asymptomatic fractures in spinal X-ray. BMD was significantly lower among ESRDpatients compared to controls: lumbar 0.966 ± 0.15 vs 0.982 ± 0.15 (adjusted p = 0.037), total hip 0.852 ± 0.15 vs 0.902 ± 0.13 (adjusted p < 0.001), and femoral neck 0.733 ± 0.15 vs 0.775 ± 0.12 (adjusted p < 0.001), as were TBS (1.20 [1.11-1.30] vs 1.31 [1.19-1.43] (adjusted p < 0.001)) and BMSi (79 [71.8-84.2] vs 82. [77.5-88.9] (adjusted p = 0.005)). CONCLUSIONS:ESRDpatients undergoing transplant surgery have damaged bone health parameters (density, microarchitecture, and mechanical properties) despite acceptably controlled hyperparathyroidism. Detecting these abnormalities may assist in identifying patients at high risk of post-transplantation fractures.
Entities:
Keywords:
Bone material strength index; Bone mineral disease; Chronic kidney disease; Microindentation; Trabecular bone score
Authors: Joshua N Farr; Matthew T Drake; Shreyasee Amin; L Joseph Melton; Louise K McCready; Sundeep Khosla Journal: J Bone Miner Res Date: 2014-04 Impact factor: 6.741
Authors: Leonardo Mellibovsky; Daniel Prieto-Alhambra; Fernando Mellibovsky; Roberto Güerri-Fernández; Xavier Nogués; Connor Randall; Paul K Hansma; Adolfo Díez-Perez Journal: J Bone Miner Res Date: 2015-06-11 Impact factor: 6.741
Authors: A M Alem; D J Sherrard; D L Gillen; N S Weiss; S A Beresford; S R Heckbert; C Wong; C Stehman-Breen Journal: Kidney Int Date: 2000-07 Impact factor: 10.612
Authors: Paul Hansma; Hongmei Yu; David Schultz; Azucena Rodriguez; Eugene A Yurtsev; Jessica Orr; Simon Tang; Jon Miller; Joseph Wallace; Frank Zok; Cheng Li; Richard Souza; Alexander Proctor; Davis Brimer; Xavier Nogues-Solan; Leonardo Mellbovsky; M Jesus Peña; Oriol Diez-Ferrer; Phillip Mathews; Connor Randall; Alfred Kuo; Carol Chen; Mathilde Peters; David Kohn; Jenni Buckley; Xiaojuan Li; Lisa Pruitt; Adolfo Diez-Perez; Tamara Alliston; Valerie Weaver; Jeffrey Lotz Journal: Rev Sci Instrum Date: 2009-05 Impact factor: 1.523
Authors: Ludmila Brunerová; Petra Ronová; Jana Verešová; Petra Beranová; Jana Potoèková; Petr Kasalický; Ivan Rychlík Journal: Kidney Blood Press Res Date: 2016-06-23 Impact factor: 2.687
Authors: Hartmut H Malluche; Daniel L Davenport; Tom Cantor; Marie-Claude Monier-Faugere Journal: Clin J Am Soc Nephrol Date: 2014-06-19 Impact factor: 8.237
Authors: Eugene V McCloskey; Anders Odén; Nicholas C Harvey; William D Leslie; Didier Hans; Helena Johansson; Reinhard Barkmann; Stephanie Boutroy; Jacques Brown; Roland Chapurlat; Petra J M Elders; Yuki Fujita; Claus-C Glüer; David Goltzman; Masayuki Iki; Magnus Karlsson; Andreas Kindmark; Mark Kotowicz; Norio Kurumatani; Timothy Kwok; Oliver Lamy; Jason Leung; Kurt Lippuner; Östen Ljunggren; Mattias Lorentzon; Dan Mellström; Thomas Merlijn; Ling Oei; Claes Ohlsson; Julie A Pasco; Fernando Rivadeneira; Björn Rosengren; Elisabeth Sornay-Rendu; Pawel Szulc; Junko Tamaki; John A Kanis Journal: J Bone Miner Res Date: 2015-11-19 Impact factor: 6.741
Authors: Atsushi Endo; Michael F McTague; Elizabeth Allen; Arvind von Keudell; Michael J Weaver Journal: Arch Orthop Trauma Surg Date: 2020-05-25 Impact factor: 3.067
Authors: Maria Fusaro; Giulia Vanessa Re Sartò; Maurizio Gallieni; Laura Cosmai; Piergiorgio Messa; Maurizio Rossini; Iacopo Chiodini; Mario Plebani; Pieter Evenepoel; Nicholas Harvey; Serge Ferrari; Jorge Cannata-Andía; Andrea Trombetti; Maria Luisa Brandi; Markus Ketteler; Thomas L Nickolas; John Cunningham; Syazrah Salam; Carlo Della Rocca; Aldo Scarpa; Salvatore Minisola; Fabio Malberti; Filomena Cetani; Mario Cozzolino; Sandro Mazzaferro; Luigi Morrone; Giovanni Tripepi; Martina Zaninotto; Maria Cristina Mereu; Maura Ravera; Giuseppe Cianciolo; Gaetano La Manna; Andrea Aghi; Sandro Giannini; Luca Dalle Carbonare Journal: Nutrients Date: 2022-04-22 Impact factor: 6.706
Authors: M Schoeb; F Malgo; J J M Peeters; E M Winter; S E Papapoulos; N M Appelman-Dijkstra Journal: Osteoporos Int Date: 2020-04-08 Impact factor: 4.507
Authors: R Wakolbinger; C Muschitz; G Scheriau; G Bodlaj; R Kocijan; X Feichtinger; J E Schanda; J Haschka; H Resch; P Pietschmann Journal: Osteoporos Int Date: 2019-02-20 Impact factor: 4.507
Authors: Manuela Schoeb; Neveen A T Hamdy; Frank Malgo; Elizabeth M Winter; Natasha M Appelman-Dijkstra Journal: Front Endocrinol (Lausanne) Date: 2020-02-07 Impact factor: 5.555